{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:47:27Z","timestamp":1788306447056,"version":"build-2803163510"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,6,16]],"date-time":"2003-06-16T00:00:00Z","timestamp":1055721600000},"content-version":"vor","delay-in-days":1961,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[1998,2]]},"abstract":"<jats:sec><jats:title>OBJECTIVE<\/jats:title><jats:p>Previous endocrine studies of women with acne have produced diverse results. This study was designed to seek evidence, from endocrine and genetic studies, for impaired steroid biosynthesis in patients with acne.<\/jats:p><\/jats:sec><jats:sec><jats:title>DESIGN<\/jats:title><jats:p>Adrenal stimulation tests with synthetic adrenocorticotrophic hormone (ACTH) were performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>MEASUREMENTS<\/jats:title><jats:p>Steroid hormones were measured basally and 30 minutes after ACTH. The results were correlated with analysis of the steroid 21\u2010hydroxylase gene (<jats:italic>CYP21<\/jats:italic>).<\/jats:p><\/jats:sec><jats:sec><jats:title>PATIENTS<\/jats:title><jats:p>Fifty\u2010one consecutive female patients (mean age 27.1 years) referred with acne.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>The median plasma 17\u2010hydroxyprogesterone (17\u2010OHP) before and 30 minutes after ACTH were 2.5\u2003nmol\/l (range 1.1\u20138.2) and 7.3 (2.1\u201317.8) nmol\/l which were significantly above normal female controls (<jats:italic>n<\/jats:italic>\u2003=\u200311, mean age 25.6 years) at 1.5 (0.9\u20134.2) and 4.6 (2.6\u20138.4) nmol\/l. Eighteen of 51 acne patients showed an abnormal 17\u2010OHP response. The 21\u2010hydroxylase gene (<jats:italic>CYP21<\/jats:italic>) was examined for major deletions and for three common point mutations in 31 of the patients (14 with exaggerated 17\u2010OHP response). One patient had a deletion of <jats:italic>CYP21<\/jats:italic> on one allele consistent with carrier status for the classical congenital adrenal hyperplasia (CAH). Five patients, one of whom had a normal 17\u2010OHP response to Synacthen, were heterozygous for the val 281 leu mutation in exon 7 of the <jats:italic>CYP21<\/jats:italic> and were therefore carriers for a mutation associated with late\u2010onset CAH. One patient with a raised 17\u2010OHP response was homozygous for the splice site mutation in intron 2 and one patient with a normal 17\u2010OHP response was heterozygous for the mutation. None of the patients had the ile 172 asn mutation. Eight of the 31 acne patients who had <jats:italic>CYP21<\/jats:italic> gene analysis were carriers for mutations in the 21\u2010hydroxylase gene but only six would have been detected by an abnormal response of 17\u2010OHP on stimulation.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSION<\/jats:title><jats:p>Although alterations of the <jats:italic>CYP21<\/jats:italic> gene were more common in acne than in controls there is a poor correlation between these events and raised steroids and acne. Factors other than mild impairment of <jats:italic>CYP21<\/jats:italic> contribute to the variability of the clinical phenotype in hyperandrogenic states including acne.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2265.1998.3811205.x","type":"journal-article","created":{"date-parts":[[2003,6,16]],"date-time":"2003-06-16T12:58:00Z","timestamp":1055768280000},"page":"209-215","source":"Crossref","is-referenced-by-count":45,"title":["Carrier status for steroid 21\u2010hydroxylase deficiency is only one factor in the variable phenotype of acne"],"prefix":"10.1111","volume":"48","author":[{"given":"Lucy S.","family":"Ostlere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Rumsby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Holownia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard S.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm H. A.","family":"Rustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Honour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,6,16]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(12)90840-6"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.4.810"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(84)90040-0"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1995.tb03127.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1989.tb08208.x"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12510160"},{"key":"e_1_2_6_8_2","unstructured":"Cutler T.P.(ed.) (1985)A Suitable Case for Treatment?pp.15\u201317. Medical Education Services Oxford."},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/5.12.2039"},{"key":"e_1_2_6_10_2","unstructured":"Ebling F.J.G.&Cunliffe W.J.(1992) Disorders of sebaceous glands. InTextbook of Dermatology Vol. 3 fifth edition (eds Champion R.H. Burton J.L. & Ebling F.J.G.) p.1699. Blackwell Scientific Publications Oxford."},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-21-11-1440"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1530\/acta.0.1080537"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.9.2841"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.20.7486"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(93)90124-F"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-62-5-840"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1990.tb03750.x"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-36-3-452"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.2.241"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-57-2-320"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.3.553"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(82)90080-0"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12482303"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1993.tb00524.x"},{"key":"e_1_2_6_25_2","first-page":"1","article-title":"Non\u2010expression of a common mutation in the 21\u2010hydroxylase gene: implications for prenatal diagnosis and carrier testing","volume":"33","author":"Rumsby G.","year":"1996","journal-title":"Journal of Molecular Genetics"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12261252"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112623"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.3109\/07435809509030452"},{"key":"e_1_2_6_29_2","first-page":"650","article-title":"High frequency of nonclassical steroid 21\u2010hydroxylase deficiency","volume":"37","author":"Speiser P.W.","year":"1985","journal-title":"American Journal of Human Genetics"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198807073190104"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115897"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb01465.x"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1984.tb00403.x"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.6.1811"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2265.1998.3811205.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.3811205.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1046\/j.1365-2265.1998.3811205.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2265.1998.3811205.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:47:42Z","timestamp":1694418462000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2265.1998.3811205.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1998,2]]}},"alternative-id":["10.1046\/j.1365-2265.1998.3811205.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2265.1998.3811205.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,2]]}}}